Jayasekera, J., Zhao, A., Schechter, C., Lowry, K., Yeh, J. M., Schwartz, M. D., O'Neill, S., Wernli, K. J., Stout, N., Mandelblatt, J., Kurian, A. W., & Isaacs, C. (2023). Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. Journal of Clinical Oncology, 41(4), 859-870. https://doi.org/10.1200/jco.22.01342
Page updated April 9, 2025 | published January 1, 2023